Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity

Journal of Neurotrauma

Volumn 31, Issue 24, 2014, Pages 1967-1974

  Umebayashi, Daisuke ^a   Natsume, Atsushi ^a   Takeuchi, Hideyuki ^b   Hara, Masahito ^a   Nishimura, Yusuke ^a   Fukuyama, Ryuichi ^d   Sumiyoshi, Naoyuki ^c   Wakabayashi, Toshihiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c Aichi Prefectural Welfare Federation of Agriculture Co operative Associations Konan Kosei Hospital   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; EXCITATORY AMINO ACID; FUSED HETEROCYCLIC RINGS; GLUTAMIC ACID; INI-0602; NEUROPROTECTIVE AGENT;

ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEMALE; GAP JUNCTION; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROGLIA; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACIDS; FEMALE; GAP JUNCTIONS; GLUTAMIC ACID; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROGLIA; NEUROPROTECTIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD INJURIES;

EID: 84906894094     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3223     Document Type: Article

References (41)

1. Takeuchi, H. (2010). Neurotoxicity by microglia: Mechanisms and potential therapeutic strategy. Clin. Exp. Neuroimmunol. 1, 12-21.
2. Benveniste, H., Jorgensen, M.B., Sandberg, M., Christensen, T., Hagberg, H., and Diemer, N.H. (1989). Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J. Cereb Blood Flow Metab. 9, 629-639.
3. Choi, D.W. (1985). Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58, 293-297.
4. Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., and Suzumura, A. (2006). Tumor necrosis factor-Alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281, 21362-21368.
5. Barger, S.W., and Basile, A.S. (2001). Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 76, 846-854.
6. Piani, D., Spranger, M., Frei, K., Schaffner, A., and Fontana, A. (1992). Macrophage-induced cytotoxicity of N-methyl-D-Aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22, 2429-2436.
7. Mungrue, I.N., and Bredt, D.S. (2004). nNOS at a glance: Implications for brain and brawn. J. Cell Sci. 117, 2627-2629.
8. Yiu, G., and He, Z. (2006). Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 7, 617-627.
9. Kempermann, G., and Neumann, H. (2003). Neuroscience. Microglia: The enemy within? Science 302, 1689-1690.
10. Kipnis, J., Avidan, H., Caspi, R.R., and Schwartz, M. (2004). Dual effect of CD4 + CD25 + regulatory T cells in neurodegeneration: A dialogue with microglia. Proc. Natl. Acad. Sci. U.S.A. 101, Suppl 2, 14663-14669.
11. Koenigsknecht, J., and Landreth, G. (2004). Microglial phagocytosis of fibrillar beta-Amyloid through a beta1 integrin-dependent mechanism. J. Neurosci. 24, 9838-9846.
12. Schwab, J.M., and Schluesener, H.J. (2004). Microglia rules: Insights into microglial-neuronal signaling. Cell Death Differ. 11, 1245-1246.
13. Zietlow, R., Dunnett, S.B., and Fawcett, J.W. (1999). The effect of microglia on embryonic dopaminergic neuronal survival in vitro: Diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur. J. Neurosci. 11, 1657-1667.
14. Takeuchi, H., Mizoguchi, H., Doi, Y., Jin, S., Noda, M., Liang, J., Li, H., Zhou, Y., Mori, R., Yasuoka, S., Li, E., Parajuli, B., Kawanokuchi, J., Sonobe, Y., Sato, J., Yamanaka, K., Sobue, G., Mizuno, T., and Suzumura, A. (2011). Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimers disease. PloS one 6, e21108.
15. Takeuchi, H., Jin, S., Suzuki, H., Doi, Y., Liang, J., Kawanokuchi, J., Mizuno, T., Sawada, M., and Suzumura, A. (2008). Blockade of microglial glutamate release protects against ischemic brain injury. Exp. Neurol. 214, 144-146.
16. Olson, J.K. (2010). Immune response by microglia in the spinal cord. Ann. N. Y. Acad. Sci. 1198, 271-278.
17. Popovich, P.G., Guan, Z., Wei, P., Huitinga, I., van Rooijen, N., and Stokes, B.T. (1999). Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158, 351-365.
18. Horn, K.P., Busch, S.A., Hawthorne, A.L., van Rooijen, N., and Silver, J. (2008). Another barrier to regeneration in the CNS: Activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J. Neurosci. 28, 9330-9341.
19. Basso, D.M., Fisher, L.C., Anderson, A.J., Jakeman, L.B., McTigue, D.M., and Popovich, P.G. (2006). Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635-659.
20. Suzuki, H., Fukuyama, R., Hasegawa, Y., Tamaki, T., Nishio, M., Nakashima, T., and Tatematsu, M. (2009). Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncol. 45, 891-897.
21. Philips, T., and Robberecht, W. (2011). Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease. Lancet Neurol. 10, 253-263.
22. O'Carroll, S.J., Gorrie, C.A., Velamoor, S., Green, C.R., and Nicholson, L.F. (2013). Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injury. Neurosci. Res. 75, 256-267.
23. Cronin, M., Anderson, P.N., Cook, J.E., Green, C.R.,. J. and Becker, D.L. (2008). Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol. Cell. Neurosci. 39, 152-160.
24. Wang, J., Ma, M., Locovei, S., Keane, R.W., and Dahl, G. (2007). Modulation of membrane channel currents by gap junction protein mimetic peptides: Size matters. Am. J. Physiology Cell Physiol. 293, C1112-C1119.
25. Bedner, P., Steinhauser, C. and Theis, M. (2012). Functional redundancy and compensation among members of gap junction protein families? Biochim. Biophys. Acta 1818, 1971-1984.
26. Gaietta, G., Deerinck, T.J., Adams, S.R., Bouwer, J., Tour, O., Laird, D.W., Sosinsky, G.E., Tsien, R.Y., and Ellisman, M.H. (2002). Multicolor and electron microscopic imaging of connexin trafficking. Science 296, 503-507.
27. Hunter, A.W., Jourdan, J., and Gourdie, R.G. (2003). Fusion of GFP to the carboxyl terminus of connexin43 increases gap junction size in HeLa cells. Cell Commun. Adhes. 10, 211-214.
28. Lopez, P., Balicki, D., Buehler, L.K., Falk, M.M., and Chen, S.C. (2001). Distribution and dynamics of gap junction channels revealed in living cells. Cell Commun. Adhes. 8, 237-242.
29. Contreras, J.E., Saez, J.C., Bukauskas, F.F., and Bennett, M.V. (2003). Gating and regulation of connexin 43 (Cx43) hemichannels. Proc. Natl. Acad Sci. U.S.A. 100, 11388-11393.
30. Bukauskas, F.F., Jordan, K., Bukauskiene, A., Bennett, M.V., Lampe, P.D., Laird, D.W., and Verselis, V.K. (2000). Clustering of connexin 43-enhanced green fluorescent protein gap junction channels and functional coupling in living cells. Proc. Natl. Acad. Aci. U.S.A. 97, 2556--561.
31. Ogata, T., Nakamura, Y., Shibata, T., and Kataoka, K. (1992). Release of excitatory amino acids from cultured hippocampal astrocytes induced by a hypoxic-hypoglycemic stimulation. J. Neurochem. 58, 1957-1959.
32. Morino, T., Ogata, T., Horiuchi, H., Takeba, J., Okumura, H., Miyazaki, T., and Yamamoto, H. (2003). Delayed neuronal damage related to microglia proliferation after mild spinal cord compression injury. Neurosci. Res. 46, 309-318.
33. De Vuyst, E., Decrock, E., De Bock, M., Yamasaki, H., Naus, C.C., Evans, W.H., and Leybaert, L. (2007). Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. . Biol. Cell 18, 34-46.
34. Thompson, R.J., Zhou, N., and MacVicar, B.A. (2006). Ischemia opens neuronal gap junction hemichannels. Science 312, 924-927.
35. Orellana, J.A., Saez, P.J., Shoji, K.F., Schalper, K.A., Palacios-Prado, N., Velarde, V., Giaume, C., Bennett, M.V., and Saez, J.C. (2009). Modulation of brain hemichannels and gap junction channels by proinflammatory agents and their possible role in neurodegeneration. Antiox. Redox. Signal. 11, 369-399.
36. Takeuchi, H. (2013). Roles of glial cells in neuroinflammation and neurodegeneration. Clin. Exp. Neuroimmunol. 4, 2-16.
37. Lin, J.H., Weigel, H., Cotrina, M.L., Liu, S., Bueno, E., Hansen, A.J., Hansen, T.W., Goldman, S., and Nedergaard, M. (1998). Gapjunction-mediated propagation and amplification of cell injury. Nat. Neurosci. 1, 494-500.
38. Ito, M., Natsume, A., Takeuchi, H., Shimato, S., Ohno, M., Wakabayashi, T., and Yoshida, J. (2009). Type I interferon inhibits astrocytic gliosis and promotes functional recovery after spinal cord injury by deactivation of the MEK/ERK pathway. J. Neurotrauma 26, 41-53.
39. Nishimura, Y., Natsume, A., Ito, M., Hara, M., Motomura, K., Fukuyama, R., Sumiyoshi, N., Aoki, I., Saga, T., Lee, H.J., Wakabayashi, T., and Kim, S.U. (2013) Interferon-beta delivery via human neural stem cell abates glial scar formation in spinal cord injury. Cell Transplant. 22,2187-2201.
40. Okada, S., Nakamura, M., Katoh, H., Miyao, T., Shimazaki, T., Ishii, K., Yamane, J., Yoshimura, A., Iwamoto, Y., Toyama, Y., and Okano, H. (2006). Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 12, 829-834.
41. Rolls, A., Shechter, R., and Schwartz, M. (2009). The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 10, 235-241.